Postdoctoral Researcher in Tumor Virology and Cancer Immunotherapy
Listed on 2026-07-31
-
Research/Development
Postdoctoral Research Fellow, Research Scientist, Immunology Research, Biomedical Science
Postdoctoral Researcher in Tumor Virology and Cancer Immunotherapy
Location:
University of Pennsylvania Perelman School of Medicine
Open Date:
Dec 29, 2025
The laboratory of Professor Jianxin You in the Department of Microbiology at the University of Pennsylvania is seeking highly motivated postdoctoral researchers interested in developing innovative therapeutic strategies for stimulating anti‑tumor immunity.
Our research focuses on how molecular interactions between oncogenic viruses and host cells drive cancer (Cell 117:349-360;Cell Host & Microbe 19:775-787). We are also developing nanotechnology-based immunotherapies to elicit antiviral and anti‑tumor immunity against human cancers caused by tumor viruses (Proc Natl Acad Sci U S
A. 2020;117:).
We invite applications from enthusiastic and highly motivated candidates for postdoctoral positions in these areas.
The position is open to applications from U.S. citizens and foreign nationals.
To learn more about our research, please visit our website: https://(Use the "Apply for this Job" box below)./p8187283
QualificationsSuccessful candidates will have a recently earned or expected Ph.D., an outstanding record of scientific productivity, and extensive research experience in biochemistry, molecular biology, cell biology, cancer, nanotechnology, or a related biological science, along with a strong publication record in these areas.
Equal Employment Opportunity StatementThe University of Pennsylvania is an equal opportunity employer. Candidates are considered for employment without regard to race, color, sex, sexual orientation, religion, creed, national origin (including shared ancestry or ethnic characteristics), citizenship status, age, disability, veteran status or any class protected under applicable federal, state, or local law.
#J-18808-Ljbffr(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).